The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding to ...

Every year on December 10, advocates around the world observe International Animal Rights Day, a reminder that animals ...

We can replace joints, lenses, even organs—but not the brain. As neuroscience unravels the mechanisms of neurodegeneration, ...

The sudden ascent of the AI therapist seems startlingly futuristic, as if it should be unfolding in some later time when the ...

Aldeyra ’s Reproxalap is the core catalyst. The FDA will make its decision on this asset by March 16, 2026, after a ...

Aspinall was deemed unable to continue by a cageside physician following Gane's double eye-poke and was sent to the hospital ...

The PRIMA system is a subretinal implant designed to restore central vision in GA patients by replacing failed photoreceptors ...

Children with amblyopia who used the AmblyoPlay app 5 days a week for 6 months had significant improvements in visual acuity, ...

Ocugen rises 75% YTD as it advances three gene therapies, with multiple phase II/III readouts and filings lined up for 2026.

While visual training will likely continue to be a productive part of treatment for people with hemianopia, the EPFL study ...

Joel S. Schuman, MD, FACS, highlights home tonometry, virtual visual fields, and portable OCT devices as promising tools, ...

Drag superstar The Vivienne, musicians Ozzy Osbourne, D'Angelo and Brian Wison and Oscar winners Diane Keaton and Robert ...